Seeking Alpha

Pluristem Therapeutics (PSTI) resumes trading 14.4% lower after shares were halted following...

Pluristem Therapeutics (PSTI) resumes trading 14.4% lower after shares were halted following news that the FDA has suspended the Phase II trials for the company's placenta-based cell treatment for artery disease.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs